Schulz Fran 4
4 · Senti Biosciences, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Schulz Fran
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-07+43,900→ 43,900 totalExercise: $3.52Exp: 2035-03-06→ Common Stock (43,900 underlying)
Footnotes (1)
- [F1]100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.